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Abstract
Background: Multiple studies have shown that plasma levels of the pro-inflammatory cytokine interleukin-6 (IL-6) are
elevated in patients with important and prevalent adverse health conditions, including atherosclerosis, diabetes, obesity,
obstructive sleep apnea, hypertension, and frailty. Higher plasma levels of IL-6, in turn, increase the risk of many conditions
associated with aging including age-related cognitive decline. However, the mechanisms underlying this association
between IL-6 and cognitive vulnerability remain unclear.
Methods and Findings: We investigated the role of IL-6 in brain aging in young (4 mo) and aged (24 mo) wild-type C57BL6
and genetically-matched IL-6
2/2 mice, and determined that IL-6 was necessary and sufficient for increased neuronal
expression of the superoxide-producing immune enzyme, NADPH-oxidase, and this was mediated by non-canonical NFkB
signaling. Furthermore, superoxide production by NADPH-oxidase was directly responsible for age-related loss of
parvalbumin (PV)-expressing GABAergic interneurons, neurons essential for normal information processing, encoding, and
retrieval in hippocampus and cortex. Targeted deletion of IL-6 or elimination of superoxide by chronic treatment with a
superoxide-dismutase mimetic prevented age-related loss of PV-interneurons and reversed age-related cognitive deficits on
three standard tests of spatial learning and recall.
Conclusions: Present results indicate that IL-6 mediates age-related loss of critical PV-expressing GABAergic interneurons
through increased neuronal NADPH-oxidase-derived superoxide production, and that rescue of these interneurons
preserves cognitive performance in aging mice, suggesting that elevated peripheral IL-6 levels may be directly and
mechanistically linked to long-lasting cognitive deficits in even normal older individuals. Further, because PV-interneurons
are also selectively affected by commonly used anesthetic agents and drugs, our findings imply that IL-6 levels may predict
adverse CNS effects in older patients exposed to these compounds through specific derangements in inhibitory
interneurons, and that therapies directed at lowering IL-6 may have cognitive benefits clinically.
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Introduction
Multiple studies have found that circulating markers of
inflammation, including interleukin-6 (IL-6), are increased in
older individuals[1–3] and are strongly associated with enhanced
risk of disease and disability[3]. Longitudinal studies on centenar-
ians and long-lived human populations indicate that longevity is
inversely correlated with plasma levels of IL-6[2,4], and
conversely, that higher plasma levels of this interleukin increase
the risk of many conditions associated with aging[5], including
age-related cognitive decline[3,6–8]. In recent epidemiologic
studies, peripheral IL-6 levels showed an inverse correlation with
cognitive function in aged subjects[3,6], with chronic elevation of
peripheral IL-6 associated with mild cognitive deficits[7], even in
apparently healthy community-living older adults[8]. Elevated
circulating IL-6 also enhances risk of stroke and dementia in older
individuals[9] and has been shown to predict future cognitive
decline[6]. Despite this body of literature, the specific mechanisms
which link peripheral IL-6 and central nervous system impairment
are still largely unknown.
In the periphery, IL-6 is well characterized as a pleiotropic
cytokine with trophic effects on T-cells and other immune cells
(reviewed in [2,3,10]). IL-6 also acts as an important pro-
inflammatory cytokine and key mediator of the acute phase
response, including induction of C-reactive protein (CRP).
Canonical IL-6 signaling involves binding of IL-6 to its cognate
receptor (IL-6R)[11] to cause dimerization of two gp130 proteins,
which in turn activate intracellular signaling and transcriptional
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and activators of transcription) pathway, and the transcription
factor SOCS3 (suppressor of cytokine signaling-3). An alternative
signaling pathway involves cleavage of the full-length membrane-
bound IL-6R to produce the soluble sIL-6R, which binds to IL-6
and can then activate gp130 signaling directly, even in cells lacking
membrane IL-6 receptors(reviewed in [2]). Our understanding of
the biology of IL-6 in the nervous system is more limited. Brain
expression of IL-6 has been shown to mediate the sickness
behavior, a syndrome of neurocognitive changes in response to
acute infection which includes lethargy, confusion, and cognitive
deficits[12]. Emerging evidence, however, suggests a more
complex role for brain IL-6 in CNS function, including
modulation of glutamatergic neurotransmission[13,14].
We have recently reported in a mouse model of schizophrenia
that administration of the dissociative anesthetic and drug-of-
abuse, ketamine, to young mice increased brain expression of IL-6
and NADPH oxidase (Nox2)[15]. Nox2, originally described as
the neutrophil respiratory burst oxidase, generates the reactive
oxygen species (ROS), superoxide, through one-electron reduction
of oxygen by NADPH. Recent studies on genetically modified
mice suggest that elevated superoxide in brain may be a critical
mediator of age-related cognitive deficits[16]. Overexpression of
the cytosolic superoxide dismutase (SOD1), or the extracellular
SOD (EC-SOD), but not the mitochondrial MnSOD (SOD2),
reverses age-associated impairment of long-term potentiation
(LTP), and prevents loss of spatial memory[16]. In addition, aged
gp91
phox2/2 mice, which are deficient in Nox2, have better
cognitive performance on memory tasks than age-matched wild-
type controls[17]. It is plausible, therefore, that a cytosolic and/or
extracellular source of superoxide production such as Nox2 might
be an important mediator of age-related cognitive deficits.
Nox2 activation in neurons can result in dysfunction of the fast-
spiking, parvalbumin (PV)-expressing subpopulation of inhibitory
GABAergic interneurons[18], required for coordinated firing of
excitatory neurons in cortex and hippocampus, and known to be
important for the encoding and retrieval of hippocampal-
dependent memory[19,20], as well as for the generation of spatial
and temporal cues. These interneurons are also involved in
attentional-shift abilities, a function attributed to the pre-frontal
cortex[21]. Age-associated loss of cortical and hippocampal
GABAergic function has been reported for rats, primates, humans,
and dogs[22–25], and is believed to contribute to aging-related
cognitive deficits. However, the processes underlying these age-
related changes in GABAergic inhibitory systems are not clear. In
the present study, we wished to determine whether IL-6 is a
mediator of age-related changes in brain, and if so the underlying
mechanisms that are regulated by IL-6.
Results
Aging increases IL-6 in plasma and brain
Multiple clinical studies have found that plasma IL-6 levels are
significantly elevated in older humans[3], with nearly undetectable
levels in young adults and levels generally .5 pg/ml in older
subjects. To determine whether similar changes occurred in old
C57BL6 mice, plasma IL-6 concentrations were measured in
randomly-selected healthy old (24 mo) and young mice (4 mo) by
ELISA. Levels in old mice were nearly 15-fold higher than young
(Fig. 1a). To analyze whether increased plasma IL-6 levels would
translate to elevation of the interleukin in brain, we measured
brain IL-6 mRNA by RT-qPCR (Fig. 1b) and found increased
levels in old C57BL6 mice, as previously found for comparably
aged Balb/c mice[26].
Increased Nox2 protein expression in brain of aged
animals is attenuated in IL-6-/- mice
We have previously determined that Nox2 is the main source of
neuronal superoxide production in a mouse model of schizophre-
nia[18]. Moreover, we recently demonstrated that IL-6 can
directly induce and activate Nox2 protein expression in cultured
neurons[15], but in that study in young mice, acute peripheral
injection of IL-6 failed to induce brain Nox2 expression. In the
context of chronically elevated peripheral IL-6 in aged animals, on
the other hand, we wished to determine whether aging was
associated with an increase in Nox2 expression in brain, by
analyzing Nox2 protein expression in young (4 month old) and old
(24 month old) mouse brain. Confocal images of double-
immunostaining for Nox2 and the neuronal marker MAP2 in
the CA1 region of the hippocampus demonstrated significantly
higher protein expression in old animals (Fig. 1c). There were rare
GFAP-positive astrocytes which also expressed Nox2. We also
found almost no Nox2-expressing cells that also were positive for
CD11b (activated microglia). Thus, more than 95% or all Nox2-
expressing cells in aged mice were Map2-postive neurons. The
specificity of the antibody was assessed by staining of equivalent
brain regions from Nox2-deficient (gp91
phox-/-) animals (Fig. 1c
bottom panels). To quantify the age-related increase in Nox2
expression, and assess whether IL-6 was involved in this process,
we determined levels of Nox2 protein in young and old wild-type
(C57BL/6) and IL-6-deficient (IL-6-/-) animals. A substantial
increase in Nox2 protein was observed in extracts prepared from
old wild-type mice, which was absent in similar age IL-6-deficient
animals (Fig. 1d, e).
Age-related increased superoxide production in brain in
vivo is attenuated by inhibition of NADPH oxidase or by
treatment with a superoxide dismutase mimetic, and is
emulated by increased levels of plasma IL-6
To confirm that elevation of brain IL-6 and induction of Nox2
described above led to increased Nox2-dependent superoxide
production in vivo, we assessed superoxide levels using confocal
imaging of dihydroethidium (DHE) oxidation to its fluorescent
product (ox-DHE) in fixed brain slices prepared from DHE-
injected young mice, and from DHE-injected old mice that had
been treated for 7 days prior to DHE with either no drug, or with
the NADPH oxidase inhibitor, apocynin, in their drinking water.
Fluorescence from oxidized DHE in neurons from cortex and
hippocampus was quantified as previously described[18,27].
Increased neuronal superoxide production observed in old animals
was significantly attenuated by apocynin treatment (Fig. 2a, b),
strongly supporting the role of Nox2 in this increase. In addition,
the requirement for IL-6 in this increase was confirmed by
showing that old IL-6-/- mice have significantly lower superoxide
levels compared to old wild-type mice (Fig. S1). We also
determined that systemic administration of the SOD-mimetic,
C3, for three weeks was sufficient to reduce ongoing superoxide
production in aged wild-type animals (Fig. 2a and b). DHE
oxidation was also evaluated in live mice using a GE eXplore
Optix whole animal fluorescence scanner, which allows visualiza-
tion of DHE oxidation in the intact animal. This technique also
demonstrated increased superoxide production in old versus young
mice, as well as in mice injected directly with IL-6 (Fig. 2c).
We next determined that increasing plasma IL-6 levels by direct
peripheral injection of IL-6 enhances Nox2 expression and
superoxide production in brain. Repeated intraperitoneal injection
of IL-6 (5 mg/kg i.p. every 12 hours times 3) in mice significantly
increased expression of Nox2 protein in brain (Fig. 2d, top) and
IL-6 and Cognitive Changes
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by DHE oxidation (Fig. 2d, bottom).
Effects of IL-6 and IL-6 deficiency on Nox2 activity:
oximetry and EPR spectroscopy in synaptosomes from IL-
6-treated and IL-6-/- mice
To further study the effects of IL-6 on neuronal Nox2 activation
in aging, we carried out a series of studies in synaptosomes
prepared from young and old wild-type and IL-6-/- mice, and in
old mice injected with IL-6. We have previously reported the use
of synaptosomes to carry out concurrent measurement of oxygen
consumption (oximetry) and superoxide radical production (by
electron paramagnetic resonance EPR)[18] allowing assessment of
both Nox-dependent oxygen utilization and superoxide produc-
tion in the same sample. NADPH-stimulated O2 consumption was
significantly higher in synaptosomes prepared from old animals
compared to young (F(1,16)=11.03, P,0.05), and this increase was
completely prevented by co-incubation with the Nox inhibitor,
apocynin (F(1,16)=40.95, P,0.0001) (Fig. 3a). Superoxide pro-
duction in the same samples, assessed by EPR, was also higher in
old animals (F(1,4)=24.92, P,0.001) (Figure 3b, c). The increase
in synaptosomal superoxide production in old mice was signifi-
cantly blocked by two different Nox inhibitors, aminoethyl-
benzenesulfonylfluoride (AEBSF) and apocynin (Figure 3c). Sta-
tistics for 200 mM apocynin were: young: 24.166.5% inhibition,
P=0.02; old: 33.563.3% inhibition, P=0.01, and for 200 mM
AEBSF were: young: 25.264.1% inhibition, P=0.003; old:
32.4610.7% inhibition, P=0.04. Control studies verified that
neither apocynin nor AEBSF were acting as direct superoxide
scavengers, and we confirmed that synaptic mitochondrial
respiration and superoxide production was not altered by the
conditions used to study Nox2 activity (Fig. S2).
Previous studies have reported that Nox2 and Nox4 are the only
NADPH oxidase isoforms expressed in the adult mouse nervous
Figure 1. Aging increases plasma and brain levels of IL-6, and induces Nox2 protein expression which is blocked by targeted
deletion of IL-6. (a) Plasma IL-6 was measured by ELISA in young (4 month) and old (24 month) C57BL6 mice and was significantly increased in old
mice; n=4, mean6SEM (F(1,6)=9.530, P=0.021). (b) IL-6 mRNA expression was determined by real-time PCR in brain and was also increased
significantly in old animals; n=4, mean6SEM (F(1,6)=10.288, P=0.018). (c) Confocal imaging of brain slices prepared from young (4 months) and old
(23 months) mice depicting Nox2 (green) and MAP2 (red) immunoreactivity in the CA1 hippocampal region. Nox2 expression was increased in old
animals with respect to young, whereas this staining was absent in slices prepared from Nox2-deficient (gp91phox -/-, 12 months old) mice.
Bar=100 mm. For immunofluorescence detection AlexaFluor 488 and 568 conjugated secondary antibodies were used. Merged images show co-
localization in yellow. (d, e) Western blot analysis of brain protein extracts obtained from young and old wild-type and IL-6-/- mice showed increased
Nox2 expression with age which was significantly lower in old IL-6-/- mouse brain (n=4, p,0.05, mean6SEM). Expression in young animals, either
WT or IL-6-/-, was below detection levels. Lack of the Nox2 band in brain proteins extracted from an old gp91phox-/- mouse (far right lane) confirmed
specificity of the anti-Nox2 antibody and location of Nox2- specific band. N=4 animals per age per genotype (F(3,12)=9.704, P=0.002, *young versus
old, P,0.05;
# old versus old-IL6-/-, P,0.05 by Tukey’s).
doi:10.1371/journal.pone.0005518.g001
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mice as well (Dugan and Zheng, unpublished). Nox2 requires co-
assembly with not only p22
phox , but its p47
phox and p67
phox
subunits for activity, whereas Nox4 has been shown to be active in
the absence of p47
phox and p67
phox [29]. Since apocynin and
AEBSF block translocation and binding of p47
phox to the Nox-
p22
phox complex, Nox4 is insensitive to these inhibitors, as
previously reported[30–32]. Therefore, Nox2 represents the only
apocynin-inhibitable NADPH oxidase isoform expressed in aged
mouse brain. Collectively, these results suggest that synaptic Nox2
activity is significantly and specifically increased in aged mice.
To study the effect of IL-6 on synaptosomal Nox2 activity, we
measured NADPH-driven O2 consumption and superoxide
production in young mice 16 hours after repeated injection of
either saline or IL-6 (5 mg/kg, i.p. on 2 consecutive days). IL-6
injected mice had significantly greater NADPH-dependent oxygen
consumption (Fig. 3a, F(1,12)=5.05, p,0.01) and superoxide
production (Fig. 3b, F(1,6)=15.26, p,0.01) than saline controls.
We then evaluated synaptosomes prepared from young and old
IL-6-/- mice, and found that compared to old wild-type controls,
IL-6-/- mice had an attenuation of age-induced increases in Nox2
O2 consumption (Fig. 3a, (F(1,6)=15.57, p,0.01) and superoxide
production (Fig. 3c, d, F(1,6)=6.34, p,0.05). In fact, Nox2 activity
in old IL-6-/- mice was not significantly different than that
observed in young wild-type mice. In Figure 3d we compare the
NADPH-triggered superoxide ‘‘burst’’ in synaptosomes isolated
from wild type old and IL6-/- old mice using spin-trapping EPR
spectroscopy. The superoxide burst produced by synaptosomes
from IL6-/- old brain was significantly less than from wild-type
synaptosomes, confirming a key role for IL-6 on Nox-induced
superoxide production at the synapse.
Parvalbumin-positive interneurons are decreased in aged
prefrontal cortex and hippocampus
Dysfunction of hippocampal mediated processes has been
associated with age-related cognitive decline [33]. Spatial learning,
Figure 2. Imaging of in vivo superoxide production in brain of young and old animals: role of Nox2 and IL-6. (a) Confocal imaging of in
vivo DHE oxidation reveals that superoxide-mediated DHE oxidation is increased in neurons in old mice, and this increase is blocked by the NADPH
oxidase inhibitor, apocynin, or by the SOD mimetic, C3. Young (4 mo) and old (24 mo) mice were treated orally for 7 days with the Nox inhibitor,
apocynin, or for 21 days with the SOD mimetic, C3. (b) Quantitative analyses of fluorescence in hippocampal CA1 and cortex were performed as
described in detail in the methods section. Images were obtained using a 406 WI objective. Values are mean6SEM, n=3. Significance was
determined by ANOVA: for CA1 (*old versus young, P=0.01;**old versus old+apocynin (P=0.02) or old+C3 (P=0.01) and cortex (Ctx) (*old versus
young, P=0.01;**old versus old+apocynin (P=0.01) or old+C3 (P=0.006) by Tukey’s. (c) Live animal imaging of DHE oxidation using a GE eXplore
Optix
TM-MX2 whole animal scanner also demonstrates increased DHE oxidation in brain of old (24 mo) relative to young (4 mo) mice. Fluorescence
images of brain through intact skull and skin are shown on the left , and fluorescence intensity from ox-DHE is mapped onto a linear pseudocolor
scale. Images to the right are ex vivo scans of the same brains showing greater anatomical detail, including fluorescence from the cortical
hemispheres and cerebellum. (d) Repeated injections of IL-6 on two consecutive days (5 mg/kg) in old mice induced Nox2 expression (top images,
green), and produced a small increase in DHE oxidation (red). However, repeated injections of IL-6 every 12 h (5 mg/kg, times three) to produce
sustained systemic levels resulted in a dramatic increased in ox-DHE fluorescence compared to saline-injected old controls (bottom images). Note
that the laser excitation power was decreased from 260 mW in (c) to 100 mW (d) to avoid saturating the camera in the scanner.
doi:10.1371/journal.pone.0005518.g002
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both healthy humans and rodents as they age[33], and has been
correlated with disruption of glutamatergic transmission in frontal
cortex and hippocampus in mice and non-human primates
[34,35]. We have recently reported that blockade of NMDA
receptors by the drug-of-abuse, and dissociative anesthetic
ketamine leads to increased Nox2 activity in brain, and is
associated with damage to parvalbumin-positive (PV) GABAergic
inhibitory interneurons[18]. The robust induction of Nox2
expression and activity we observed led us to ask whether PV
inhibitory interneurons might also be selectively lost during aging,
as well. We found a substantial and highly significant loss of PV-
interneurons in aged hippocampus (Fig. 4), with the CA2-3 region
being the most affected (20% decrease for CA1, main effect of age:
F(1,17)=34.4, P,0.05; 45% decrease for CA2-3: main effect of
age: F(1,17)=378.7, P,0.05; 33%, 17% decrease for DG, main
effect of age: F(1,17)=20.1, P,0.05) (Fig. 5b), as well as a 17%
decrease in prelimbic cortex (Fig. S3, P=0.007 by t-test). To
determine whether old mice lacking IL-6, which had lower Nox2
expression and superoxide production in brain would have
preservation of PV-interneurons during aging, we carried out
analysis in young and old wild-type and IL-6-/- mice. IL-6
deficiency attenuated the age-related loss of PV-interneurons
(Fig. 4c); two-way ANOVA analysis of the genotype6age
interaction showed a statistically significant effect for area CA3
(F(1,23)=23.9, P,0.001) and a strong trend for area CA1
(F(1,23)=3.1, P=0.09). Rescue of cells in the dentate gyrus was
difficult to determine because the small number of PV-interneu-
rons in this region. To assess whether a sustained reduction in
brain superoxide levels would also preserve PV-interneurons, we
analyzed brain slices from mice treated chronically with an SOD
mimetic, and found that C3 treatment also prevented the age-
related loss of PV-interneurons, as well (Fig. 4b; main effect of
treatment for CA1: F(2,22)=4.9, P=0.035; main effect of
Figure 3. Increased synaptosomal Nox-2 activation and superoxide production in old wild-type mice is absent in old IL-6-/- mice;
determination by electrochemical oxygen consumption analysis and EPR spin-trapping spectroscopy. (a) NADPH-induced oxygen
consumption is significantly decreased by the Nox inhibitor apocynin (300 mM, black bars). Oxygen consumption by synaptosomal Nox from the
cortex of young (3–4 M, n=9) and old (23–24 M, n=9) animals at 37uC was induced by the addition of 5 mM NADPH to samples containing 2–5 mg
synaptosomal protein. The observed Nox specific activity was significantly higher in IL-6 injected young animals (white bars, p=0.04, n=5) and in old
brains (light gray bar, p=0.01, n=9) and was significantly lower in IL-6-/- old mice (dark gray bar, p=0.04, n=4). IL-6 treatment: Two IL-6 i.p.
injections (5 mg/kg), separated by 12 hrs were administered to young and old animals before the groups were sacrificed 12 hrs later for
synaptosomal isolation. (b) Representative EPR spectra recorded 3 minutes after mixing 5 mM NADPH with 0.2–0.5 mg synaptosomal protein
isolated from brain of old mice at 37uC with 70 mM DEPMPO in the absence or in the presence of 200 mM AEBSF or 300 mM apocynin. In each
incubation, 10 mM DETC was included to inhibit the SOD enzyme, resulting in enhanced and quantifiable EPR signals. Using computer simulations
we concluded that the observed signals are attributable to a mixture of adducts of DEPMPO with hydroxyl radical and lipid derived carbon centered
radical and both radicals are derived from superoxide since the signals were completely abolished in the presence of SOD; not shown. (c)
Quantification of the observed EPR signals accumulated over the first 3 minutes from NADPH addition, n=4–9 per group. Superoxide yield in
synaptosomes isolated from different groups follows essentially the same activity pattern seen by oxygraphy and shown in (a). The asterisks (*)
designate statistical significance by ANOVA followed by Tukey test with respect to young control while (#) indicate statistical significance with
respect to old control. EPR settings are described fully in methods. Data are mean 6 SEM. (d) Nox-generated superoxide burst in synaptosomes
isolated from IL-6-/- KO mice is significantly lower than that in their old control brains.
doi:10.1371/journal.pone.0005518.g003
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for analysis of PV-interneurons in PFC.
Nuclear translocation of NFkB is increased in aged brain,
and mediates IL-6 induction and activation of Nox2 in
neurons
The activation and nuclear translocation of the transcription
factor NFkB is involved in signaling mechanisms that lead to
increased inflammatory cytokine expression. Conversely, IL-6 has
recently been shown in an epithelial tumor cell line to activate
NFkB signaling through non-canonical binding of unphosphory-
lated STAT3 (U-STAT3) to NFkB, releasing inhibition by IkB.
The U-STAT3-NFkB dimer then translocates to the nucleus and
activates a subset of NFkB-dependent genes[36]. Although both
Nox2 and its p22
phox subunit are NFkB target genes, the question
of whether IL-6 can act through NFkB to induce Nox2 or p22
phox
has not been previously addressed. We therefore analyzed whether
nuclear translocation of NFkB was elevated in forebrains of old
mice, by detection of the p65 subunit using a commercially
available EMSA kit (TransAM). Mouse forebrain nuclear extracts
showed increased content of the p65 subunit when compared to
similar extracts prepared from young animals (Fig. 5a). The age-
related increase in nuclear translocation of NFkB was absent in old
IL-6-/- mice, suggesting that NFkB is involved in the CNS effects
of IL-6 (Fig. 5a). To further understand the relationship between
nuclear translocation of NFkB and the activation of superoxide
production by Nox2, we utilized a primary neuronal culture
Figure 4. PV Interneurons are decreased with aging, but spared in IL-6 -/- mice or mice treated chronically with an SOD mimetic, C3.
(a) Images, depicting the regions analyzed for PV-interneuron immunostaining in the prelimbic region (between Bregma 2.2 and 1.9), and dorsal
hippocampus (between Bregmas 21.2 and 21.7). Four consecutive slices were analyzed for each animal. All cells in the regions were counted, and
counts per slice were calculated as described in Methods (b) PV-cell counts in the regions of CA1, CA3 and dentate gyrus (DG) of old and old-C3
treated animals are expressed as % of their control. Aging was accompanied by a statistically significant decrease in PV-interneuron number in all
regions analyzed and treatment of animals from middle age with the SOD-mimetic C3 (Old-C3) prevented the reduction of PV-interneuron numbers in
CA1 and CA3, but not in DG. (c) The loss of PV neurons in all of the studied regions was partially rescued in IL-6 KO mice. * indicates statistical
significance with respect to young animals (P,0.05) and # indicates statistical significance with respect to old animals (P,0.05) as determined by
ANOVA followed by Tukey’s test. YM and OM: n=9 animals per group; OM + C3: n=7 animals.
doi:10.1371/journal.pone.0005518.g004
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6-dependent induction and activation of Nox2[15]. Exposure of
these cultures to IL-6 in the absence and presence of SN50 (5 mM),
a cell permeable peptide which blocks NFkB nuclear transloca-
tion[37], demonstrated that inhibiting NFkB-mediated transcrip-
tional events completely prevented IL-6-mediated induction of
Nox2 expression and superoxide production (Fig. 5b, c) and
prevented the loss of GABAergic phenotype of PV-interneurons
(Fig. 5d, e), as demonstrated by loss of PV and GAD67
immunoreactivity. The specificity of SN50 has previously been
confirmed in these same cultures by EMSA using an inactive
peptide, SN50M.[37] These results suggest that Nox2 activation/
induction is dependent on NFkB-mediated transcription in
neurons.
IL-6 deficiency, or reduction of neuronal superoxide
production, ameliorates impaired spatial learning in
normal aging mice
The PV-interneuronal GABAergic system is responsible for the
control of cortical output and the generation of gamma
oscillations, involved in temporal-encoding and storage/recall of
information required for the correct functioning of working
memory processes[38]. To analyze the possible correlation
between the number of PV-interneurons in the old brain and
cognitive ability, we subjected old animals to a series of simple
memory tasks and compared their performance to that of similar
age animals deficient in IL-6 production. Short term spatial
memory recognition was tested by analyzing habituation to the
spatial distribution of objects in an open field (novel object
exploration task, Fig. 6a). Three objects were used for this task: a
monkey, a zebra and a horse, for which the mice showed equal
preference. There were significant overall genotypic differences in
contacting the objects (monkey: F(1,23)=8.6, P,0.01; zebra:
F(1,23)=5.9, P,0.05; and horse: F(1,23)=8.7, P,0.01) with IL-6-
deficient animals making more overall contacts than wild-type
mice. In all cases there were significant effects of trial, with
decreases in contacts over trials. In addition, there were significant
genotype6trial interactions in exploration of the monkey
(F(2,46)=15.1, P,0.0001), horse (F(2,46)=5.8, P,0.01), and
moderately for the zebra (F(2,48)=3.1, P=0.05). IL-6 deficient
mice showed a greater degree of habituation to object exploration
Figure 5. IL-6-induction of Nox2 and subsequent decrease of parvalbumin and GAD67 expression in PV-positive interneurons is
NFkB-dependent. Nuclear extracts of brain samples obtained from wild-type or IL-6-deficient animals were analyzed for content of the NFkB p65
subunit by colorimetric quantification of p65 using a commercially available kit (TransAM). A high concentration of p65 was found in nuclear extracts
obtained from old wild type mice (a), and this was greatly diminished in nuclear extracts obtained from similar-age IL-6 deficient mice. The specificity
of the binding to wild type oligonucleotide was confirmed by competition with either sense (oligo) or mutated oligonucleotides (mutant oligo).
ANOVA analysis yielded a significant effect of genotype (F(1,18)=9.414, P,0.05). (b) Application of IL-6 to neurons in culture induced Nox2 expression
(b, top panel) and DHE oxidation (b, bottom panel and c) that was blocked by the NFkB inhibitor SN50. Dissociated primary neuronal cultures were
treated with IL-6 (10 ng/ml) for 24 h in the absence or presence of SN50 (5 mM), an inhibitor of NFkB nuclear translocation. Dihydroethidium (DHE,
1 mg/ml) was applied for the last hour as described[18]. After fixation, cells were immunostained for Nox2. *=significant with respect to control.
#=significant with respect to IL-6, F(2,346)=12.826, P,0.05). (d. e) SN50 also prevented the decrease in expression of parvalbumin and GAD67
induced by IL-6 exposure in PV-interneurons (*F(2,409)=234.7, P,0.05;
#F(2,409)=192.8, P,0.05).
doi:10.1371/journal.pone.0005518.g005
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higher in IL-6 deficient mice, but there was no floor effect limiting
habituation in wild-type mice. Thus, these data suggest greater
object recognition memory formation in IL-6 deficient mice. In
the Barnes maze test, latencies to locate the escape chamber over
the first 4 days of training were analyzed. This is the phase of the
experiment where the strategy for escaping is developing and there
is typically a significant decrease in escape latencies observed
across this time in young mice. In this case, the aged wild-type
mice did not display a significant decrease in escape latencies
across the first 4 trials (F(3,27)=1.4, P=0.25); whereas the IL-6
deficient mice did (F(3,27)=5.0, P,0.01) Fig. 6b). This also
suggests greater spatial memory consolidation in IL-6-/- mice.
To rule out possible differences in motor ability between genotypes
we evaluated locomotor activity and found no baseline differences
between genotypes.
Rescue of PV-interneurons in hippocampus was observed not
only in IL-6 deficient mice, but in mice treated long-term treatment
with an SOD mimetic (C3). Therefore, to explore the relationship
between preservation of PV-interneurons and hippocampal forms
of memory in C3-treated mice, we analyzed data from the probe
component of the Morris water maze for the specific mice used for
the PV-interneuron counts. Mice were tested on the Morris water
maze as previously described[27]. The number of platform
crossings over the area where the removed platform had been
located was measured (higher score is better performance). Old
males had significantly fewer platform crossings than young males,
indicating that spatial memory is reduced in old males (Fig. 6c), On
the other hand, aged C3-treated mice performed significantly better
than wild-type old mice, showing that treatment with the SOD
mimetic preserves spatial memory in aged mice. Data were
analyzed by 2-way ANOVA and Tukey’s post-hoc test.
Discussion
Increased plasma IL-6 is an independent risk factor for many
diseases associated with aging, including type 2 diabetes,
atherosclerosis, hypertension, frailty, and cardiovascular ischemia,
and is a significant predictor of delirium, psychosis, stroke,
transition from mild cognitive impairment (MCI) to Alzheimer’s
disease (AD)[3,7], and progression of AD in older individuals[2,3].
Recent studies also suggest that even in healthy older adults
without MCI or AD, circulating IL-6 is inversely correlated with
cognitive performance, and that there is a linear relationship
between elevated plasma IL-6 and poor cognitive function.
Because of this consistent association between higher plasma IL-
6 and adverse health outcomes, IL-6 was named ‘‘the gerontol-
ogist’s cytokine’’ by William Ershler, who speculated that this
cytokine regulates a key aging pathway in man[39]. However, the
question of whether IL-6 is primarily a marker or is mechanis-
tically integral to age-related nervous system dysfunction has not
been established.
We found that expression of Nox2, the respiratory burst
oxidase, was significantly increased in neurons throughout the
hippocampus and cortex in aged mouse brain, as documented by
immunocytochemistry, Western blot analysis, and mRNA (data
not shown). Increased Nox2 protein was associated with enhanced
Nox2 activity and superoxide production in neurons and in
synaptosomes, and in fact, Nox2 appeared to be the major source
of increased cytosolic and synaptosomal superoxide production in
old animals. This was supported by results showing that systemic
administration of the Nox inhibitor, apocynin reduced superoxide
production in neurons in vivo to levels similar to those in young
animals. Moreover, two chemically distinct Nox inhibitors,
apocynin and AEBSF, fully blocked the age-related increase in
Nox2 activity (O2 consumption) in synaptosomes prepared from
old animals, and apocynin reduced synaptosomal superoxide
production to levels in young synaptosomes, as well. Our data
further indicated that Nox2 is tonically active in neurons in vivo,a s
evidenced by ongoing neuronal superoxide production in normal
awake mice which was blocked not only by apocynin, but by oral
treatment with the SOD mimetic, C3. Nox2 was also found to be
constitutively active in synaptosomes; Nox2-dependent O2 con-
sumption and superoxide production in synaptosomes was
Figure 6. Old IL-6-/- mice or old mice treated with the SOD mimetic, C3, exhibit preserved spatial working memory. (a) Old IL-6-/- mice
show improved learning performance on the Novel Object task. Old (22 month) C57BL6 and IL-6-/- mice (on a C57B6 background) were tested for
habituation to each of three novel objects, and IL-6-/- mice showed significantly better performance than wild-type mice (statistics shown in Results).
(b) Barne’s maze escape latency (time to find the darkened chamber) showed a statistically significant decrease in latency in old IL-6-/- mice but wild-
type mice (statistics included in results section). (c) Preservation of spatial learning and memory on the Morris water maze by chronic treatment with
C3. Young (6 M), old (24 M), and old-C3-treated (24 M) male mice were tested on components of the Morris water maze as previously described[27].
Graph shows performance on the probe trial component for the specific set of male mice used in the current study. Data from the probe component
of the trial are shown for the immediate (1 h) recall, and delayed (24 h) recall. C3 significantly preserved performance at both time-points. Data are
mean6SEM, and were analyzed by 2-Way ANOVA followed by Tukey’s post-hoc test, n=13 young, n=10 old, n=12 old-C3.
doi:10.1371/journal.pone.0005518.g006
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in contrast to a number of other studies which have required
agents, such as phorbol esters, to induce assembly of the Nox2
complex, required no other additions to observe O2 consumption
and superoxide generation. These results suggest that in neurons
and at the synapse, Nox2 is in the assembled, superoxide-capable
form, and is responsible for a sustained increase in neuronal and
synaptic superoxide production in the aged brain. Thus, we
believe this to be the first report that Nox2 is the major source of
neuronal and synaptic superoxide production in normal aging
brain.
There has been debate over whether apocynin inhibits the
p47
phox-dependent Nox isoforms (Nox1, Nox2, Nox4, and Nox5),
with a recent paper suggesting that in vascular smooth muscle
cells, apocynin may be acting as an antioxidant rather than a
NADPH oxidase inhibitor, and that standard chemiluminescence-
based assays for Nox activity may produce artifacts in the presence
of apocynin [40]. However, there are also several recent studies
supporting efficacy of apocynin as a Nox2 inhibitor[30,41],
reviewed in [42], with the use of appropriate controls. We have
previously shown, using EPR and oximetry as measures of Nox2
activity, that apocynin is not acting as an antioxidant in our system
([15,18]), that it lacks activity when Nox2 is not induced, and that
it does not affect mitochondrial superoxide generation in the same
sample [15,18]. Of note, myeloperoxidase, which is required to
convert apocynin to its active dimer, is expressed in neurons and
astrocytes in brain[43-45].
The role of IL-6 in mediating age-related induction of neuronal
Nox2 was then examined in old IL-6-/- mice, and in wild-type mice
treated directly with IL-6. IL-6-/- mice lack the age-related increase
inNox2 expressionandsuperoxideproductionobservedinoldwild-
type mice. Nox-dependent superoxide production in synaptosomes
was also significantly lower in old IL-6-/- mice compared to wild-
type mice, and was not statistically different than superoxide
production inyoung synaptosomes. Consistentwitha directeffect of
IL-6 on Nox2 expression, direct systemic injection of IL-6 into mice
increased Nox2 protein and activity, confirming the ability of
peripheral IL-6 to mediate increased Nox2 expression and
superoxide production in brain. Live-animal imaging of in vivo ox-
DHE fluorescence followed by confocal microfluorimetry of cell-
specific DHE oxidation in slices prepared from live-imaged animals
provided additional support for increased superoxide production in
aging that was increased even further by IL-6 injection.
Factors responsible for peripheral IL-6 induction in aging
humans include diet, hormone status, activity, and genet-
ics[2,3,5,46,47], and while mechanisms which increase IL-6 in
the nervous system are less well understood, direct entry of plasma
IL-6 into brain has been shown[12]. Stress effects on the
hypopituitary axis can also lead to local induction of IL-6 in
brain and secondary release into blood, a potential additional
source of IL-6 in both brain and plasma[3] (and references
therein). Our ability to induce Nox2 in brain by direct peripheral
IL-6 administration suggests that the former process may be
operative in our experiments. Of note, these studies were carried
out in male mice only, and given the fact that have previously
reported higher CNS superoxide levels in aged female versus male
C57BL6 mice[48], we speculate that gender-specific differences in
inflammatory signaling in brain might contribute to this difference.
Induction of Nox2 by IL-6 in neurons was dependent on NFkB
signaling. The decreased expression of Nox2 we observed in old
IL-6-/- mice compared to wild-type mice was accompanied by a
significant reduction in nuclear NFkB activity. Although IL-1b
and TNFa are strong inducers of NFkB activation, expression of
these two cytokines, measured by RT-qPCR, was not statistically
different between old wild-type and old IL-6-/- mice (data not
shown) suggesting that the specific loss of IL-6 expression, not
changes in these other cytokines, was responsible for decreased
nuclear NFkB activity in aged IL-6-/- mouse brain. More
importantly, direct application of IL-6 to cultured neurons resulted
in a significant increase in Nox-2 expression and superoxide
production which was fully blocked by the NFkB translocation
inhibitor, SN50. It has recently been shown in epithelial tumor
cells that IL-6 activates NFkB signaling through binding of
unphosphorylated STAT3 (U-STAT3) to NFkB, promoting
STAT3-NFkB translocation to the nucleus via nuclear targeting
sequences in STAT3, resulting in subsequent transcription of a
subset of NFkB-dependent genes[36]. However, it has become
increasingly clear that NFkB signaling is highly complex, and is
dependent on the stimulus, tissue, cell type, and context. For
example, NFkB activated by TNFa induces transcription of a
panel of genes, including IL-6 and RANTES, whereas NFkB
activation by notch fails to induce these two genes. Therefore,
although both Nox2 and p22
phox are classic NFkB target genes
which are induced by TNFa and IL-1b, this is to our knowledge,
the first report that IL-6 acting through non-canonical NFkB
signaling can directly induce Nox2 expression in neurons.
Recent work has suggested that the brain maintains a
physiological range of superoxide production that is required for
normal nervous system function. Perturbations of superoxide levels
in either direction are associated with impaired LTP, altered
glutamatergic neurotransmission, and poorer cognitive perfor-
mance. Elevated levels of superoxide associated with aging have
specifically been shown to mediate deficits in learning and
memory[27,49,50]. Thus, superoxide in brain has been the focus
of several recent studies on cognitive deficits in aging.
Increased neuronal superoxide production at the synapse,
specifically the glutamatergic synapse, can affect a number of
redox-regulated proteins important to synaptic activity and
plasticity [18,51]. Dysregulation of the activity of these proteins
would in turn affect normal glutamatergic transmission, and thus
cognition. We recently reported that acute (days) elevation of
superoxide production in brain by ketamine caused the loss of
phenotype of PV-interneurons, as demonstrated by reduced PV
and GAD67 immunoreactivity, which recovered over a few days.
In contrast, here we show that sustained superoxide production by
Nox2 during aging produces a significant decrease in these same
neurons throughout hippocampus and prefrontal cortex. There
was loss of 45%, 20%, 33%, and 17% of these neurons in
hippocampal CA3, CA1, DG, and prefrontal cortex, respectively,
in 24 month-old mice. This decline was completely rescued by
treatment of mice with the small molecule SOD mimetic, C3, from
middle age. Systemic treatment with C3 has been previously shown
to reduce brain superoxide levels significantly. These results
strongly suggest that sustained Nox-dependent superoxide pro-
duction during aging may be responsible for the decline in PV-
interneuron numbers. In addition, as predicted by our results
showing that injected IL-6 induces brain Nox2, and that IL-6-/-
mice lack induction of Nox2, there was preservation of these
interneurons in aged IL-6-/- mice which was highly significant for
CA3, and approached significance for CA1. While our data
suggest that neurons are the primary source of Nox2-derived
synaptic superoxide, and that in this model of non-pathological
aging, very few astrocytes have detectable Nox2 protein or
superoxide production, there is no way to rule out local Nox-
dependent superoxide release by astrocytes at the synapse as
contributing to the observed effects.
PV-interneurons subserve an important role in cognitive
processes, and are critically positioned to modulate hippocampal
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losswasobserved inall regions ofhippocampus,aswell asprefrontal
cortex, the most pronounced decrease was in CA2-3. Both IL-6-/-
mice and C3-treated mice showed preservation of PV-interneurons
in CA3, and C3 rescued interneurons in CA1, as well. The CA3a,b
region of hippocampus has been shown to be critical for detection of
novelty[52], spatial learning[53], and for encoding of new spatial
information into short-term memory[52,54–56]. Importantly,
impaired spatial learning and memory is consistently reported
acrossstudiesinolderadults,andthis isfound even inthe absence of
a dementing illness[53,55]. While CA1 is generally believed to be
necessary for encoding of temporal but not spatial information, it is
believed to be involved retrieval of spatial information previously
encoded by CA3[56,57]. Thus, the behavioral correlates of deficits
in CA3 neural circuitry would be decreased novelty recognition and
impaired spatial learning[58], and for CA1, decreased spatial
working memory[56,57]; and both areas are believed necessary for
effective performance on the probe component of the Morris water
maze. To determine whether rescue of PV-interneurons was
associated with improved cognitive performance, we carried out
behavioral testing, and found that aged IL-6-/- mice, which had
significant preservation of PV-neurons in CA3, had significantly
greater recognition of three novel objects, and then showed greater
habituation to compared to wild-type controls. Habituation to a
novel environment tests simple learning[52,58] without the need for
aversive stimuli, and has been shown to be impaired in animals with
lesions to CA3. In addition, while aged wild-type mice showed
impaired abilitiesinfindingthe escapechamber inthe Barnesmaze,
IL-6-/- mice progressively found the escape chamber more quickly
across trials. Thus, IL-6 deficiency appears to decrease learning
deficits attributable to CA3 in aged mice. We further evaluated
spatial learning and memory in aged mice treated long-term with a
SOD mimetic. Mice treated chronically with C3 had significant
rescue of PV-interneurons in both CA1 and CA3. Consistent with
the importance of these regions to spatial memory, treated mice had
significantly better performance on the probe component of the
Morris water maze. Of note, a virtual Morris water maze for
humans has been developed[59,60] and has revealed that older
humans show a nearly identical decline in performance on the
probe trial component[59,60]. Taken together, our data suggest
that lossofPV-interneuronsinthe hippocampus could underlie age-
related cognitive deficits in older humans. Furthermore, the data
suggests that decreasing IL-6 induction of Nox2, or eliminating
downstream superoxide production directly can preserve cognitive
performance.
Increased circulating IL-6 is a highly prevalent finding in older
adults, with estimates based on the clinical literature that more
than 80% of individuals over the age of 65 will have circulating
levels of IL-6 greater than 5 pg/ml. This indicates that a sizeable
and growing number of older individuals might be at risk for IL-6-
mediated cognitive effects. In addition, our results showing that
sustained elevation of peripheral IL-6 results in loss of PV-
interneurons with aging provide several clinically-testable hypoth-
eses. The PV-interneurons targeted by IL-6 represent the same
interneuron population that is selectively vulnerable to injury from
commonly-used general anesthetics, and this vulnerability is
observed even at low doses of these agents. Thus, the use of
general anesthetics in patients with chronic elevation of circulating
IL-6 might be predicted to increase the risk of adverse cognitive
outcomes after anesthesia. Because treatments which lower plasma
IL-6 levels and/or block IL-6 signaling are currently in clinical use
for other indications, these agents could be used to test idea that
lowering IL-6 may preserve in the integrity of the PV-inhibitory
system and prevent associated cognitive deficits. Clinical testing of
the mechanisms presented here could further contribute to our
broader understanding of the role of inflammatory signaling in
both physiology and pathology the brain.
Methods
Materials
Antibodies used were as follows: anti-parvalbumin rabbit
polyclonal was from Swant (Bellizona, Switzerland), and anti-
GAD67 monoclonal from Chemicon (Millipore). Polyclonal anti-
Nox2 was from Santa Cruz Biotechnology Inc. (Santa Cruz,
California), and monoclonal anti Nox2 was from BD Transduc-
tion, or a generous gift of Mark Quinn (Montana State University).
Unless otherwise stated, all reagents were from Sigma and tissue
culture media from Invitrogen. The spin traps 5-(diisopropox-
yphosphoryl)-5-methyl-1-pyrroline-N-oxide (DIPPMPO) and 5-
(diethylphosphoryl)-5-methyl-1-pyrroline-N-oxide (DEPMPO)
were from Alexis Biochemicals (San Diego, CA). The NFkB
inhibitor, SN50, was from Calbiochem (San Diego, CA).
Maintenance of mice, and administration of dihydroe-
thidium (DHE), apocynin, IL-6, and the SOD mimetic, C3.
Male C57BL/6, gp91phox(-/-)and IL-6(-/-) mice were obtained from
Jackson Labsat 8 weeks of age and housed in our facility until 12–
15 weeks (young), or 22–26 months of age (old), when they were used
for experiments. DHE was injected as described[27]. Briefly, two
serial i.p. injections of freshly prepared dihydroethidium (27 mg/kg)
are given at 30 minute intervals. Eighteen hours later, mice are
anesthetized with inhaled halothane, and perfused intracardially with
cold saline followed by 4% paraformaldehyde in PBS for
immunohisto-chemistry experiments, or their brains dissected and
forebrains processed for synaptosomal preparations (as described
below).
Apocynin (5 mg/kg/day) was administered in the drinking water
for7 days. IL-6 injections were 5 mg/kgi.p.on2 consecutivedays as
described[15], except for in vivo imaging, in which an additional
5 mg/kg injection was given between the first and last injection. C3
was given in the drinking water at 1 mg/kg/day starting at
12 months of age as described[27] for cell counts, or for 21 days for
DHE studies. All animal studies were approved by the Animal Care
Program at the University of California, San Diego, and are in
accordance the PHS Guide for the Care and Use of Laboratory
Animals, USDA Regulations, and the AVMA Panel on Euthanasia.
Synaptosomal preparations. Synaptosomes were prepared
from adult mouse forebrain as described[18].
Cortical neuronal cultures were prepared form cortices of Swiss
Webster E15 mouse embryos and grown on poly-lysine coated
coverslipswithparaffin‘‘feet’’for21daysaspreviouslydescribed[18].
RT-PCR. RNA was extracted from mouse forebrain using
Trizol. After reverse transcription of mRNA (1 mg), the cDNA
produced was analyzed for IL-6, IL-1b,a n dT N F a expression using
a c t i na sa ni n t e r n a lc o n t r o l .P C Rw a sc a r r i e do u tb yC F A R
Genomics Core at UCSD. PCR conditions were the following
45 secondsat95uC,15 secondsat45uC, and 1 minute at72uCfor35
cycles. IL-6 primers: forward: 59-atggatgctaccaaactggat-39 and
reverse: 59-tgaaggactctggctttgtct-39. IL-1b primers: 59-caaccaacaa-
gtgatattctccatg-39 and reverse: 59-gatccacactctccagctgca-39.T N F a
primers: 59-catcttctcaaaattcgagtgacaa-39 and reverse: 59-tgggagta-
gacaaggtacaaccc-39. GAPDH primers: forward: 59-gaacatcatcc-
ctgcctctactgg-39 and reverse: 59-tccaccaccctgttgctgta-39.
Superoxide detection in synaptosomes by electron
paramagnetic resonance (EPR) spectroscopy
Detection of NADPH-dependent superoxide production in
synaptosomal preparations was performed using spin-trapping EPR
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0.2 mg synaptosomal protein) were mixed with 70 mM DEPMPO
(5-(diethylphosphoryl)-5-methyl-1-pyrroline-N-oxide) and appropri-
ate combinations of substrates/inhibitors, and loaded into a 50 ml-
glass capillary, which is inserted into the EPR cavity of a MiniScope
MS200 Benchtop spectrometer, maintained at 37uC. Previous
control experiments have confirmed that the EPR signals are
substrate specific, acquired only in the presence of synaptosomes, and
not due to redox cycling of reagents used[18]. EPR signals
accumulated during the first 6 minutes after addition of NADPH
were measured. To be able to detect all superoxide generated, the
SOD inhibitor diethyldithiocarbamic acid (DETC; 5 mM) was
included in the assay mixture. When analyzing the effects of direct
addition of IL-6 on superoxide production in synaptosomes, IL-6
(100 ng/ml, final) was added to synaptosomes 5 minutes before Nox
oxidaseactivity was initiated by addition of substrate (NADPH,5 mM
final). EPR conditions were: microwave power, 5 mW; modulation
amplitude, 2 G;modulation frequency, 100 kHz; sweep width, 150 G
centered at 3349.0 G; scan rate, 7.5 G s
21,w i t he a c hs p e c t r u m
representing the average of 5 scans.
Immunocytochemistry. Fixation of neurons in culture was
performed as described[61]. For dual-label immunostaining,
coverslips were incubated in 2% normal goat serum (NGS)
containing the following primary antibodies (Ab): anti-GAD67
monoclonal (1:1000), anti-Nox2 rabbit polyclonal (1:200), anti-
parvalbumin rabbit polyclonal (1:4000), and incubated for 2 h at
37uC. Specific binding was detected by incubation for 45 min at
room temperature with a 1:1000 dilution of AlexaFluor secondary
Abs (568: red; 488: green).
Immunohistochemistry. Brains were sliced using a
vibratome into 50 mm coronal sections. As previously
described[27], 6 sequential slices, encompassing either the
prelimbic region (from Bregma 2.0 to 1.3), or dorsal
hippocampal formation, were processed by floating-section
fluorescence immunohistochemistry to detect Nox2 and
MAP2[18]. For PV-interneuron counting, slices were processed
as before and incubated with anti-Parvalbumin antibody (1:5000)
for 48 h, washed in PBS and developed using a Vectastain ABC
kit according to manufacturer’s instructions
Confocal microscopy, live animal fluorescence imaging,
and image analysis. Mounted slices or coverslips were
evaluated for fluorescence under settings for 488 and 568
excitation on a LSM510 Meta multiphoton laser confocal
microscope using 106 or 406 water immersion objective.
Oxidized DHE fluorescence was analyzed using Ex l 543 nm,
Em l.590 nm. Imaging for PV-interneuron counting was
performed using a transmitted light. All PV-positive interneurons
were counted in the regions described in Figs 5 and suppl. 2.
Image analysis of the neuronal population in primary cultures
was essentially as described [61]. Briefly, coverslips are scanned to
obtain 200–400 neurons (approx. 26–30 images captured per
coverslip per condition using a 406 water immersion objective).
Each image analyzed consists of a stack of 16 0.2 mm Z-stage
images taken from the base of the neurons and across 3.2 mm
depth. When analyzing PV-interneurons in particular, the
coverslips are scanned to obtain images as before but all PV-
interneurons on the coverslip are imaged. Experiments were
performed in duplicate coverslips of neurons prepared from the
same dissection across at least three different dissections.
Confocal microscope settings were maintained constant for each
series of experiments so that the resulting images could be
analyzed by densitometry and the treatment-dependent changes in
fluorescence compared and expressed as % of control (for primary
cultures) or saline (for in vivo) conditions. For each experiment,
both in vitro and in vivo, controls (saline) were processed in
parallel such that variability due to antibody batch or laser power
could be avoided. Neurons in the images were then analyzed for
their somatic median green and red fluorescence intensity per cell
using MetaMorph (linear scale of 0–255 pixel intensity units).
Live animal imaging of oxidized DHE (ox-DHE) fluorescence in
brain was carried out as described[62]. Briefly, anesthesia was
induced in mice injected 16 hours previously with DHE using
inhaled isofluorane. Mice were then placed in a eXplore Optix
TM-
MX2 system whole animal scanner (Advanced Research Tech-
nologies, Inc., Montreal, Canada), and maintained on isofluorane
anesthesia by nose-cone. Fluorescence images were obtained by
raster-scanning a region over brain using a step size of 0.5 mm
with 1 second integration time.
Behavioral testing. The novel object habituation test was
adapted from the Novel Object/Location test as described[63]. To
habituate each mouse to the testing environment, they were
individually placed in an empty testing chamber (a
51 cm651 cm639 cm opaque Plexiglas box) for 5 minutes prior to
the beginning of testing. Each mouse was then moved to a holding
cage, and three novel objects (plastic toy animals glued to a 464i n
Plexiglas base) were placed in three corners of the testing chamber.
Afterabriefinterval,themousewasplaced backintothechamberfor
another 5 minutes; exploration was assessed by analyzing the number
of contacts, defined as nose-first approaches to within 2–4 cm of an
object, with a given object in a trial, and habituation was assessed by
comparing the number of contacts made with each object over the
course of two subsequent trials, three in all. Between animals, the
testing chamber, as well as the objects, were cleaned with AirX44
disinfectant and odor counteractant (AirX Laboratories; Folcroft,
PA), to remove olfactory cues. One week following novel object
exploration, the Barnes maze test was performed as described[64].
The Barne’s maze was carried out as previously described[65]. The
Morris water maze was carried out as described in detail[27].
Statistical analysis. For analysis of fluorescence, all intensity
values were normalized by the mean obtained for the control
treatments (medium exchange alone for cultures, saline injection
for animals), processed in parallel with the experimental group,
and expressed as a percent of this mean. To obtain the mean
fluorescence/cell/animal, percent values were averaged across six
slices from the same animal, or from the same culture plating in
the case of primary cultures on coverslips. The mean fluorescence
intensity/cell/animal (or per experiment in the case of primary
cultures) was then used to calculate the mean and standard
deviation per group. These were then used for statistical analysis
using SigmaStat software. Values obtained per experiment were
analyzed by one- or two-way ANOVA as indicated in each figure,
followed by Tukey’s post-hoc test for multiple comparisons, with
significance set at P,0.05.
Two-way ANOVA followed by Tukey’s post-hoc analysis was
used to determine significance between genotypes across time for
the Novel Object task and the Barnes Maze, or between ages and
treatment groups for the Morris water maze, and F and P values
for these comparisons are included in the appropriate figure
legend or results section.
Supporting Information
Figure S1 Superoxide imaging in IL-6-/- brain. Superoxide
levels are substantially lower in the hippocampal CA1 and cortex
regions of IL-6-/- mouse. Confocal images were acquired as
described for Figure 2a.
Found at: doi:10.1371/journal.pone.0005518.s001 (10.58 MB
TIF)
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chondrial respiration is not affected by age or IL-6 treatment.
State 3 respiration was initiated by malate plus pyruvate (10 mM
each) (ADP already present), state 4 respiration was measured after
addition of the F0F1-ATPase inhibitor, oligomycin, and maximal
respiration was measured after adding the uncoupling agent,
CCCP. IL-6 treatment: Two IL-6 i.p. injections (5 mg/kg),
separated by 12 hrs were administered to young and old animals
before the groups were sacrificed 12 hrs later for synaptosomal
isolation.
Found at: doi:10.1371/journal.pone.0005518.s002 (10.03 MB
TIF)
Figure S3 PV-interneurons in PFC. A statistically significant
decrease in PV-positive cell counts was observed in the prelimbic
region of prefrontal cortex (PFC). The region analyzed is shown at
left. Values are mean6SEM, P=0.007 by t-test.
Found at: doi:10.1371/journal.pone.0005518.s003 (10.03 MB
TIF)
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